10 completed, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 6 Phase 1, 6 Phase 2, 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 5, Active not recruiting 1 |
| Phase 2 | 6 | Completed 4, Active not recruiting 1, Not yet recruiting 1 |
| Not applicable | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Stage III Gastric Cancer: new trials by email Literature Review of Stage III Gastric Cancer trials Research Report on Stage III Gastric Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX megestrol acetate oral suspension + serplulimab + SOX, serplulimab + SOX - Stage III Gastric Cancer | Phase 2 | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 48 | 2026-02-15 | 2026-02-06 |
| Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer ONS - Stage III Gastric Cancer | Not applicable | Unknown | Jinling Hospital, China | 696 | 2022-08-01 | 2022-08-29 |
| TAS102 in Combination With NAL-IRI in Advanced GI Cancers Nanoliposomal Irinotecan, Trifluridine and Tipiracil Hydrochloride - Colorectal Adenocarcinoma, Gastric Adenocarcinoma | Phase 1 / Phase 2 | Active not recruiting | Emory University | 64 | 2018-01-30 | 2025-01-07 |
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer Best Practice, Laboratory Biomarker Analysis, Supportive Care - Acute Myeloid Leukemia, Brain Glioblastoma | Not applicable | Completed | Stanford University | 128 | 2017-08-08 | 2025-01-24 |
| Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer laboratory biomarker analysis, enzyme-linked immunosorbent assay, flow cytometry - Recurrent Colon Cancer, Recurrent Gastric Cancer | Phase 1 | Completed | City of Hope Medical Center | 12 | 2011-12-22 | 2026-10-19 |
| Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer saracatinib - Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach | Phase 2 | Completed | National Cancer Institute (NCI) | 21 | 2008-01-01 | 2018-08-23 |
| Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction erlotinib hydrochloride, oxaliplatin, fluorouracil - Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction | Phase 1 | Completed | Wake Forest University Health Sciences | 9 | 2007-04-01 | 2018-07-02 |
| S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer lapatinib ditosylate, laboratory biomarker analysis - Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach | Phase 2 | Completed | National Cancer Institute (NCI) | 40 | 2004-12-01 | 2013-01-17 |
| Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors alvespimycin hydrochloride, laboratory biomarker analysis, pharmacological study - Male Breast Cancer, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2004-07-01 | 2013-04-10 |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer EF5, motexafin lutetium, pharmacological study - Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix | Not applicable | Terminated | National Cancer Institute (NCI) | 30 | 2004-05-01 | 2013-01-16 |
| Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction Cisplatin, Computed Tomography, Fludeoxyglucose F-18 - Gastric Adenocarcinoma, Stage II Gastric Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 55 | 2003-06-01 | 2017-07-06 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer recombinant fowlpox-CEA(6D)/TRICOM vaccine, sargramostim, recombinant fowlpox GM-CSF vaccine adjuvant - Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder | Phase 1 | Completed | National Cancer Institute (NCI) | 48 | 2001-11-01 | 2013-01-25 |
| Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer bryostatin 1, cisplatin, laboratory biomarker analysis - Stage III Gastric Cancer, Stage IV Gastric Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 12 | 2000-10-01 | 2014-10-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu recombinant interleukin-12, ABI-007/carboplatin/trastuzumab - Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 15 | 1999-08-01 | 2013-02-28 |
Stomach Neoplasms (14) · Colonic Neoplasms (6) · Pancreatic Neoplasms (6) · Rectal Neoplasms (5) · Breast Neoplasms (4) · Esophageal Neoplasms (4) · Breast Neoplasms, Male (3) · Carcinoma, Hepatocellular (3) · Carcinoma, Non-Small-Cell Lung (3) · Carcinoma, Ovarian Epithelial (3) · Carcinoma, Renal Cell (3) · Gallbladder Neoplasms (3) · Salivary Gland Neoplasms (3) · Appendiceal Neoplasms (2) · Bile Duct Neoplasms (2)
Digestive System Diseases (14) · Digestive System Neoplasms (14) · Gastrointestinal Diseases (14) · Gastrointestinal Neoplasms (14) · Neoplasms (14) · Neoplasms by Site (14) · Stomach Diseases (14) · Colonic Diseases (7) · Endocrine Gland Neoplasms (7) · Endocrine System Diseases (7) · Intestinal Diseases (7) · Intestinal Neoplasms (7) · Carcinoma (6) · Colorectal Neoplasms (6) · Head and Neck Neoplasms (6)
Cisplatin (2) · Fluorodeoxyglucose F18 (2) · Irinotecan (2) · Magnetic Resonance Spectroscopy (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (1) · 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1) · Bryostatins (1) · Congresses as Topic (1) · Enzyme-Linked Immunosorbent Assay (1) · Erlotinib Hydrochloride (1) · Fish Oils (1) · Flow Cytometry (1) · Fluorouracil (1) · Gene Expression Profiling (1)
National Cancer Institute (NCI) (8) · City of Hope Medical Center (1) · Emory University (1) · Jinling Hospital, China (1) · Stanford University (1) · The First Affiliated Hospital with Nanjing Medical University (1) · Wake Forest University Health Sciences (1)
United States (12) · China (2) · Canada (1)
Arthur Blackstock (1) · David Solit (1) · Heather-Jane Au (1) · Heinz-Josef Lenz (1) · Manali Patel (1) · Manisha Shah (1) · Margaret von Mehren (1) · Olatunji B. Alese, MD (1) · Stephen Michael Hahn (1) · Syma Iqbal (1) · Vincent Chung, MD (1) · William Carson (1) · Xinying Wang, MD (1)
PMID 24987057, PMID 34749008, PMID 35771552, PMID 37041057
N01CM17101 (1), N01CM62203 (1), P01CA087971 (1), P30CA008748 (1), U01CA069856 (1), U01CA076576 (1)